When.com Web Search

  1. Ads

    related to: parkinson's medication dosage chart pdf printable

Search results

  1. Results From The WOW.Com Content Network
  2. Foscarbidopa/foslevodopa - Wikipedia

    en.wikipedia.org/wiki/Foscarbidopa/foslevodopa

    Download as PDF; Printable version; ... is a fixed-dose combination medication used for the treatment of Parkinson's disease. [2] [5] ...

  3. Carbidopa/levodopa - Wikipedia

    en.wikipedia.org/wiki/Carbidopa/levodopa

    Carbidopa/levodopa, also known as levocarb and co-careldopa, is the combination of the two medications carbidopa and levodopa. [6] It is primarily used to manage the symptoms of Parkinson's disease, but it does not slow down the disease or stop it from getting worse. [6] It is taken by mouth. [6]

  4. Category:Antiparkinsonian agents - Wikipedia

    en.wikipedia.org/wiki/Category:Antiparkinsonian...

    Generally, drugs outlined within the ATC code N04 should be included in this category. Please see WP:PHARM:CAT for more information. Wikimedia Commons has media related to Antiparkinsonian agents .

  5. Management of Parkinson's disease - Wikipedia

    en.wikipedia.org/wiki/Management_of_Parkinson's...

    In the management of Parkinson's disease, due to the chronic nature of Parkinson's disease (PD), a broad-based program is needed that includes patient and family education, support-group services, general wellness maintenance, exercise, and nutrition. At present, no cure for the disease is known, but medications or surgery can provide relief ...

  6. Trihexyphenidyl - Wikipedia

    en.wikipedia.org/wiki/Trihexyphenidyl

    Trihexyphenidyl (THP, benzhexol, trihex, marketed as Artane and others) is an antispasmodic drug used to treat stiffness, tremors, spasms, and poor muscle control. It is an agent of the antimuscarinic class and is often used in management of Parkinson's disease. It was approved by the FDA for the treatment of Parkinson's in the US in 2003. [2] [3]

  7. FDA Approves AbbVie's Parkinson's Treatment, Medicare ... - AOL

    www.aol.com/finance/fda-approves-abbvies...

    On Thursday, the FDA approved AbbVie Inc’s (NYSE:ABBV) Vyalev (foscarbidopa and foslevodopa) as the first and only subcutaneous 24-hour infusion of levodopa-based therapy for motor fluctuations ...